fashion. The first significant increases in both water intake and urine output above that of controls occurred when 4 mg/kg was administered.
The drinking and increased urine output in response to administration of 8 mg bethanechol/kg was inhibited by atropine sulfate (3 and 6 mg/kg, IP). In addition, the/3-adrenergic antagonist, propranolol (6 mg/kg, IP, administered 30 min prior to treatment with bethanechol), inhibited bethanechol (8 mg/kg, IP)-induced drinking• Urine output, however, was unaffected by propranolol.
Further, the angiotensin 1 converting enzyme inhibitor, captopril, inhibited significantly the drinking response, but not the increased urine output, accompanying administration of bethanechol (8 mg/kg). The effect of bethanechol and the/3-adrenergic agonist, isoproterenol (25 _g/kg) separately and in combination, on water intake was also studied. Both compounds increased water intake but they exerted no interactive effect when administered simultaneously. Administration of bethanechol (8 mg/kg) to conscious rats was also accompanied by a significant reduction in both mean blood pressure and heart rate that reached minimal levels within 10 rain after treatment.
Both responses had returned to control level by one hr after treatment. These results suggest that bethanechol induces drinking in rats by way of the renin-angiotensin system.
Parasympathomimetic agents Bethanechol Drinking Renin-angiotensin system BOTH central and peripheral administration of parasympathomimetic agents is well known to initiate drinking in rats [1] [2] [3] [4] [5] [6] 11] . Of the two routes of administration, the peripheral route appears to initiate drinking less reliably [5] . Thus, the dose-response relationship between dose of pilocarpine administered and water intake during 90 minutes after treatment was not linear and actually decreased when doses higher than 3 mg/kg of body weight were administered intraperitoneally [5] . One standard error is set off at each mean.
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Experiment 4
Administration of the angiotensin I converting enzyme inhibitor, captopril (35 mg/kg), inhibited the increased water intake induced by bethanechol (Table 4 ). The effect of captopril was greatest during the first hr after treatment. Its effectiveness waned considerably during the second and third hr of the experiment.
Captopril alone was without significant effect on water intake. The increased urine output and increased urinary sodium and potassium excretion rates induced by bethanechol were unaffected by simultaneous treatment with captopril.
Experiment 5
When isoproterenol (25 /zg/kg, SC) and bethanechol (8 mg/kg, IP) were administered alone, both induced a significant increase in water intake during the first and second hr after treatment (Fig.  1) . When administered together, the effects of the two treatments were additive and not interactive as determined by a two way analysis of variance.
Experiment 6
Administration of bethanechol (8 mg/kg, IP) to conscious rats with an indwelling carotid cannula was accompanied by a reduction in mean blood pressure of approximately 40 mm Hg (Fig. 2A) . The maximal depression occurred at approximately 10 rain after treatment after which mean blood pressure returned toward that of controls. By 30 min after treatment, mean blood pressure of the treated group was no longer significantly different from that of the control group. Heart rate after administration of bethanechol followed a time-course that was similar to that of mean blood pressure (Fig. 2B) . shown that both propranolol and captopril, administered alone at the doses used here, failed to affect water intake of rats [8, 9] .
A furhter suggestion that bethanechol-induced water intake uses a pathway similar to that of isoproterenol is found in the data from Experiment 5 in which these compounds were administered singly and together (Fig. 1) . The effect of simultaneous administration of the two compounds was additive rather than interactive. Thus, separate pathways for mediation of the .two drinking responses are unlikely.
